579 related articles for article (PubMed ID: 31159629)
21. Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders.
Liew TM; Feng L; Gao Q; Ng TP; Yap P
J Am Med Dir Assoc; 2015 Feb; 16(2):144-8. PubMed ID: 25282632
[TBL] [Abstract][Full Text] [Related]
22. Detection of Mild Cognitive Impairment Among Community-Dwelling African Americans Using the Montreal Cognitive Assessment.
Rossetti HC; Smith EE; Hynan LS; Lacritz LH; Cullum CM; Van Wright A; Weiner MF
Arch Clin Neuropsychol; 2019 Aug; 34(6):809-813. PubMed ID: 30517598
[TBL] [Abstract][Full Text] [Related]
23. MACE versus MoCA: equivalence or superiority? Pragmatic diagnostic test accuracy study.
Larner AJ
Int Psychogeriatr; 2017 Jun; 29(6):931-937. PubMed ID: 28264749
[TBL] [Abstract][Full Text] [Related]
24. Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal Cognitive Assessment among elderly and oldest-old Chinese population.
Tan JP; Li N; Gao J; Wang LN; Zhao YM; Yu BC; Du W; Zhang WJ; Cui LQ; Wang QS; Li JJ; Yang JS; Yu JM; Xia XN; Zhou PY
J Alzheimers Dis; 2015; 43(4):1403-12. PubMed ID: 25147113
[TBL] [Abstract][Full Text] [Related]
25. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.
Badrkhahan SZ; Sikaroodi H; Sharifi F; Kouti L; Noroozian M
Appl Neuropsychol Adult; 2020; 27(5):431-439. PubMed ID: 30821505
[TBL] [Abstract][Full Text] [Related]
26. Discriminant Potential of the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in Greek Older Adults with Subjective Cognitive Decline and Mild Cognitive Impairment.
Tsatali M; Moraitou D; Gialaouzidis M; Bakoglidou E; Psaltis V; Bertzes N; Hassanin HI; Emmanouilidou E; Totonidis M; Frantzi N; Avdikou K; Gavra A; Diamantidou A; Kapsali N; Kouroundi E; Tsolaki M
J Alzheimers Dis Rep; 2024; 8(1):543-554. PubMed ID: 38549629
[TBL] [Abstract][Full Text] [Related]
27. A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores.
Carson N; Leach L; Murphy KJ
Int J Geriatr Psychiatry; 2018 Feb; 33(2):379-388. PubMed ID: 28731508
[TBL] [Abstract][Full Text] [Related]
28. Psychometrics and diagnostic properties of the Montreal Cognitive Assessment 5-min protocol in screening for Mild Cognitive Impairment and dementia among older adults in Tanzania: A validation study.
Masika GM; Yu DSF; Li PWC; Wong A; Lin RSY
Int J Older People Nurs; 2021 Jan; 16(1):e12348. PubMed ID: 32920984
[TBL] [Abstract][Full Text] [Related]
29. Validation of the Spanish-language version of the Montreal Cognitive Assessment test in adults older than 60 years.
Delgado C; Araneda A; Behrens MI
Neurologia (Engl Ed); 2019; 34(6):376-385. PubMed ID: 28364958
[TBL] [Abstract][Full Text] [Related]
30. Screening for Cognitive Dysfunction Using the Rowland Universal Dementia Assessment Scale in Adults With Sickle Cell Disease.
Forté S; Blais F; Castonguay M; Fadiga N; Fortier-St-Pierre M; Couette M; Ward R; Béland S; Cohn M; Soulières D; Kuo KHM
JAMA Netw Open; 2021 May; 4(5):e217039. PubMed ID: 33983401
[TBL] [Abstract][Full Text] [Related]
31. Is the Montreal cognitive assessment culturally valid in a diverse geriatric primary care setting? Lessons from the Bronx.
Stimmel MB; Orkaby AR; Ayers E; Verghese J; Nsubayi CK; Weiss EF
J Am Geriatr Soc; 2024 Mar; 72(3):850-857. PubMed ID: 38196332
[TBL] [Abstract][Full Text] [Related]
32. Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample.
Papastefanakis E; Dimitraki G; Ktistaki G; Fanouriakis A; Karamaouna P; Bardos A; Kallitsakis I; Adamichou C; Gergianaki I; Repa A; Bertsias G; Sidiropoulos P; Karademas E; Simos P
Lupus; 2021 Dec; 30(14):2237-2247. PubMed ID: 34861804
[TBL] [Abstract][Full Text] [Related]
33. REMEDES for Alzheimer-R4Alz Battery: Design and Development of a New Tool of Cognitive Control Assessment for the Diagnosis of Minor and Major Neurocognitive Disorders.
Poptsi E; Tsardoulias E; Moraitou D; Symeonidis AL; Tsolaki M
J Alzheimers Dis; 2019; 72(3):783-801. PubMed ID: 31640100
[TBL] [Abstract][Full Text] [Related]
34. Accuracy of the Montreal Cognitive Assessment in Detecting Mild Cognitive Impairment and Dementia in the Rural African Population.
Masika GM; Yu DSF; Li PWC
Arch Clin Neuropsychol; 2021 Apr; 36(3):371-380. PubMed ID: 31942599
[TBL] [Abstract][Full Text] [Related]
35. An Abbreviated Montreal Cognitive Assessment (MoCA) for Dementia Screening.
Horton DK; Hynan LS; Lacritz LH; Rossetti HC; Weiner MF; Cullum CM
Clin Neuropsychol; 2015; 29(4):413-25. PubMed ID: 25978540
[TBL] [Abstract][Full Text] [Related]
36. Discriminant Validity of the WAIS-R Digit Symbol Substitution Test in Subjective Cognitive Decline, Mild Cognitive Impairment (Amnestic Subtype) and Alzheimer's Disease Dementia (ADD) in Greece.
Tsatali M; Poptsi E; Moraitou D; Agogiatou C; Bakoglidou E; Gialaouzidis M; Papasozomenou C; Soumpourou A; Tsolaki M
Brain Sci; 2021 Jun; 11(7):. PubMed ID: 34209189
[TBL] [Abstract][Full Text] [Related]
37. [Hungarian version of the Montreal Cognitive Assessment (MoCA) for screening mild cognitive impairment].
Volosin M; Janacsek K; Németh D
Psychiatr Hung; 2013; 28(4):370-92. PubMed ID: 24443573
[TBL] [Abstract][Full Text] [Related]
38. It's all about cognitive trajectory: Accuracy of the cognitive charts-MoCA in normal aging, MCI, and dementia.
Bernier PJ; Gourdeau C; Carmichael PH; Beauchemin JP; Voyer P; Hudon C; Laforce R
J Am Geriatr Soc; 2023 Jan; 71(1):214-220. PubMed ID: 36102601
[TBL] [Abstract][Full Text] [Related]
39. Screening for Mild Cognitive Impairment and Dementia with Automated, Anonymous Online and Telephone Cognitive Self-Tests.
Van Mierlo LD; Wouters H; Sikkes SA; Van der Flier WM; Prins ND; Bremer JA; Koene T; Van Hout HP
J Alzheimers Dis; 2017; 56(1):249-259. PubMed ID: 27911296
[TBL] [Abstract][Full Text] [Related]
40. Signs and symptoms method in neuropsychology: A standardized observational examination of cognitive functions can be effective in detecting mild cognitive impairment.
Trimarchi PD; Sanfilippo E; Gallucci A; Inglese S; Tomasini E; Fontanella A; Rebecchi I; Fracchia S; Parisi PMR; Tartarone F; Giunco F; Abbate C
Neuropsychology; 2023 Oct; 37(7):846-857. PubMed ID: 36442006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
